💨 Abstract
Regeneron Pharmaceuticals reported second-quarter earnings of $1.39 billion, with a profit of $12.81 per share. Adjusted earnings were $12.89 per share, surpassing Wall Street expectations of $8.03 per share. The company's revenue was $3.68 billion, exceeding forecasts of $3.34 billion.
Courtesy: WTOP Staff
Suggested
Cincinnati officials discuss city crime and widespread response to video of violent fight -
Winning numbers drawn in Friday’s Maryland Cash Pop -
BetMGM Promo Code WTOP150: Extended $150 MLB Bonus Continues for August -
Rays place All-Star first baseman Jonathan Aranda on injured list with a fractured left writs -
El esfuerzo de Trump por acabar con la ciudadanía por nacimiento enfrenta escepticismo de otro tribunal de apelaciones -
Brock Purdy’s milestone year: A $265M deal and a new baby for the 49ers QB -
Who is Erika McEntarfer, the Bureau of Labor Statistics commissioner fired by Trump? -
Hot dog spill shuts down highway in Pennsylvania commuters’ wurst nightmare -
Maddy Siegrist’s return to Wings from knee injury delayed at least 1 more game -
Can Jhoan Duran’s 100 mph fastball and Harrison Bader’s defense lead Phillies to a World Series? -